Login to access your membership accounts, education training and products and services.
San Diego, CA10/19/2017 - 10/20/2017
Babson Park, MA10/24/2017
RAPS Virtual Career Fairs are designed to connect employees with employers no matter where they might be located.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Regulatory Exchange, aka RegEx, is where members come online to learn, grow and engage with a diverse global community of regulatory professionals with similar interests and goals.
It’s well-known that the National Institutes of Health (NIH) offers billions of dollars in grants to US academic research facilities. What’s less well-known is that each year, hundreds of new inventions are produced in the laboratories of NIH, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), and these inventions are licensed out to private companies in the US and internationally for further research and development, with the hopes of bringing new products to market.
No consensus has been reached on whether the World Health Organization (WHO) should continue with its biological qualifier proposal in assigning international nonproprietary names for biosimilars, and WHO says it "will not be proceeding with this at present," according to an October report.
Welcome to our European Regulatory Roundup, our weekly overview of the top EU regulatory news.
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Categories: Features, FDA
Tags: Successful Advisory Committee, FDA Advisory Committee, Regulatory Project Teams, AdComm, advisory committee
Sign up for regular emails from RAPS. We'll never share your info and you can unsubscribe any time.
Although the new European Medicines Agency's (EMA) location will not be known until November, EMA on Friday said again that it's anticipating heavy staff losses which will not only challenge its operability but "could also result in a major deficit in its budget," according to highlights published Friday from a management board meeting this month. View More
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. View More
Republican representatives David Trott (R-MI) and Susan Brooks (R-IN) last week introduced a bill calling for the US Food and Drug Administration (FDA) to lead a new public-private working group on medical device cybersecurity. View More
The US Food and Drug Administration (FDA) on Wednesday released updated recommendations in the form of a draft guidance for the format and content of a risk evaluation and mitigation strategy (REMS) document for prescription drugs and biologics. View More